Literature DB >> 21468003

Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.

Brian Moldt1, Csaba Miskey, Nicklas Heine Staunstrup, Andreas Gogol-Döring, Rasmus O Bak, Nynne Sharma, Lajos Mátés, Zsuzsanna Izsvák, Wei Chen, Zoltán Ivics, Jacob Giehm Mikkelsen.   

Abstract

It has been previously shown that integrase-defective HIV-1-based gene vectors can serve, with moderate efficiency, as substrate for DNA transposition by a transiently expressed Sleeping Beauty (SB) transposase. Here, we describe the enhanced gene transfer properties of a HIV-1/SB hybrid vector that allows efficient DNA transposition, facilitated by the hyperactive SB100X transposase, from vector DNA intermediates in primary human cells. Potent transposase-dependent integration of genetic cargo carried by the hybrid HIV-1/SB vector (up to 160-fold above background) is reported in human cell lines as well as in primary human fibroblasts and keratinocytes. The efficiency of transgene integration in context of the newly developed hybrid vector is comparable with that of conventional lentiviral vectors (LVs). Integration profiles of integrating HIV-1-derived vectors and SB transposons mobilized from LVs are investigated by deep sequencing of a large number of integration sites. A significant bias of lentiviral integrations in genes is reported, confirming that biological properties of the viral integration machinery facilitate preferred insertion into actively transcribed genomic regions. In sharp contrast, lentiviral insertions catalyzed by the SB100X transposase are far more random with respect to genes. Based on these properties, HIV-1/SB vectors may become valuable tools for genetic engineering and therapeutic gene transfer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468003      PMCID: PMC3149173          DOI: 10.1038/mt.2011.47

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  50 in total

1.  Development of hyperactive sleeping beauty transposon vectors by mutational analysis.

Authors:  Hatem Zayed; Zsuzsanna Izsvák; Oliver Walisko; Zoltán Ivics
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

2.  Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.

Authors:  John R Ohlfest; Zachary L Demorest; Yasuhiko Motooka; Isabelita Vengco; Seunguk Oh; Eleanor Chen; Frank A Scappaticci; Rachel J Saplis; Stephen C Ekker; Walter C Low; Andrew B Freese; David A Largaespada
Journal:  Mol Ther       Date:  2005-09-16       Impact factor: 11.454

3.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

4.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

5.  Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements.

Authors:  Thomas J Vigdal; Christopher D Kaufman; Zsuzsanna Izsvák; Daniel F Voytas; Zoltán Ivics
Journal:  J Mol Biol       Date:  2002-10-25       Impact factor: 5.469

Review 6.  Molecular mechanisms of HIV integration and therapeutic intervention.

Authors:  Nick Vandegraaff; Alan Engelman
Journal:  Expert Rev Mol Med       Date:  2007-02-26       Impact factor: 5.600

7.  Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells.

Authors:  G Luo; Z Ivics; Z Izsvák; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.

Authors:  Matthew Bayer; Boris Kantor; Adam Cockrell; Hong Ma; Brian Zeithaml; Xiangping Li; Thomas McCown; Tal Kafri
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

9.  Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells.

Authors:  Stephen R Yant; Mark A Kay
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.

Authors:  Brian Moldt; Nicklas H Staunstrup; Maria Jakobsen; Rafael J Yáñez-Muñoz; Jacob G Mikkelsen
Journal:  BMC Biotechnol       Date:  2008-08-09       Impact factor: 2.563

View more
  41 in total

1.  Mobilization of DNA transposable elements from lentiviral vectors.

Authors:  Rasmus O Bak; Jacob Giehm Mikkelsen
Journal:  Mob Genet Elements       Date:  2011-07-01

2.  Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains.

Authors:  Katrin Voigt; Andreas Gogol-Döring; Csaba Miskey; Wei Chen; Toni Cathomen; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2012-07-10       Impact factor: 11.454

Review 3.  Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

4.  Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.

Authors:  Dirk Heckl; Adrian Schwarzer; Reinhard Haemmerle; Doris Steinemann; Cornelia Rudolph; Britta Skawran; Sabine Knoess; Johanna Krause; Zhixiong Li; Brigitte Schlegelberger; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

5.  Human somatic cell mutagenesis creates genetically tractable sarcomas.

Authors:  Sam D Molyneux; Paul D Waterhouse; Dawne Shelton; Yang W Shao; Christopher M Watling; Qing-Lian Tang; Isaac S Harris; Brendan C Dickson; Pirashaanthy Tharmapalan; Geir K Sandve; Xiaoyang Zhang; Swneke D Bailey; Hal Berman; Jay S Wunder; Zsuzsanna Izsvák; Zsuzsanna Iszvak; Mathieu Lupien; Tak W Mak; Rama Khokha
Journal:  Nat Genet       Date:  2014-08-17       Impact factor: 38.330

6.  Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; Lajos Mátés; Tien Yin Yau; Vladimír Landa; Vaclav Zidek; Sanum Bashir; Orsolya I Hoffmann; László Hiripi; Wiebke Garrels; Wilfried A Kues; Zsuzsanna Bösze; Aron Geurts; Michal Pravenec; Thomas Rülicke; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

7.  An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.

Authors:  Daniela Benati; Fabienne Cocchiarella; Alessandra Recchia
Journal:  J Vis Exp       Date:  2018-01-12       Impact factor: 1.355

8.  In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors.

Authors:  Maximilian Richter; Kamola Saydaminova; Roma Yumul; Rohini Krishnan; Jing Liu; Eniko-Eva Nagy; Manvendra Singh; Zsuzsanna Izsvák; Roberto Cattaneo; Wolfgang Uckert; Donna Palmer; Philip Ng; Kevin G Haworth; Hans-Peter Kiem; Anja Ehrhardt; Thalia Papayannopoulou; André Lieber
Journal:  Blood       Date:  2016-08-23       Impact factor: 22.113

Review 9.  Transposons As Tools for Functional Genomics in Vertebrate Models.

Authors:  Koichi Kawakami; David A Largaespada; Zoltán Ivics
Journal:  Trends Genet       Date:  2017-09-06       Impact factor: 11.639

10.  Germline transgenesis in pigs by cytoplasmic microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; Wiebke Garrels; Lajos Mátés; Tien Yin Yau; Sanum Bashir; Vaclav Zidek; Vladimír Landa; Aron Geurts; Michal Pravenec; Thomas Rülicke; Wilfried A Kues; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.